Trials / Completed
CompletedNCT00213525
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Healthy Controls
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years – 76 Years
- Healthy volunteers
- Accepted
Summary
Scleroderma is an autoimmune disease of unknown origin. Recently, the role of environmental factors, and particularly toxic drug exposure, in the genesis of scleroderma has been suggested. This prompted us to conduct this prospective, case-control, multicentric study, including 2 groups of subjects: * 100 patients with scleroderma * 300 sex- and age-matched healthy controls. The aim of our study is to determine whether exposure to toxics is higher in patients with scleroderma compared with healthy controls.
Detailed description
The data of patients with scleroderma and healthy controls will be compared regarding: * a standardized questionnaire about "cursus laboris" at initial inclusion * a search for toxics in blood, urine and hair: at initial exvaluation, 6 month and 2 year-follow-up
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnary for environmental factors research | Questionnary for environmental factors research |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2005-09-21
- Last updated
- 2015-02-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00213525. Inclusion in this directory is not an endorsement.